Author: ec2WPAdmin

May 30 2018

Visit us at the 2018 SNMMI Show!
  Come visit ec² Software Solutions and Numa at this year’s annual meeting! You will have the opportunity to meet our team members and learn about our industry leading software products.   You will also have a chance to win a pair of AirPods during our 3 day raffle!   If you cannot attend the event but would like […]
Read More >
Oct 21 2016

RENEWAL vs REGISTRATION Reference Guide
There have been many questions such as: “Our NMIS computer has a message appear saying we have 26 days to register. Is this something that is necessary? Are we due for our annual upgrade? Do we need to renew our software? What do I need to register?  How do I register?” These are common questions […]
Read More >
Oct 05 2016

ec² Software Solutions is Looking Forward to Seeing You at EANM 2016
ec² Software Solutions will be exhibiting at the upcoming European Association of Nuclear Medicine’s Annual Meeting this October. Held October 15-19th, in Barcelona, Spain. ec² Software Solutions will be previewing their newest NMIS and BioDose programs. They will also be demonstrating BioTrax QMS, a quality management system designed specifically for PET Manufacturing. Their software suite includes; NMIS, BioDose, […]
Read More >
Mar 03 2016

How To Dispose of Nuclear Pharmaceuticals
Federal regulations require hospitals and outpatient facilities to keep a record of the distribution of radiopharmaceuticals. They are required to track dosage amounts and radiation readings. When theses facilities need to dispose of the radiopharmaceutical inventory, they send the containers back to the manufacturer and report this to the FDA. The steps taken can be […]
Read More >
Mar 03 2016

The Importance of Diagnostic Radiopharmaceuticals
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person’s specific organs. Diagnostic procedures using radioisotopes are becoming more routine due to the valuable information they can provide. Why Use Radiopharmaceuticals? Every organ in our bodies acts differently from a chemical point of view. Nuclear medicine researchers have identified many chemicals […]
Read More >
Mar 03 2016

FDA goes Mobile
Last month, the FDA launched a new mobile application to provide the public with access to information about drug shortages. The app is mostly for health care professionals and pharmacists, who will be able to get real-time information about current shortages, resolved shortages, and discontinuations of drugs. Users can browse by a drug’s generic, name, […]
Read More >
Sep 10 2015

Fetal Radiation Doses with PET, PET/CT, and PET/MR Imaging
The second article in our new Recent Highlights Series discusses the recent article “Fetal Radiation Dose from 18F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR” by Zanotti-Fregonara et al. published in the Journal of Nuclear Medicine (volume 56, issue 8, pages 1218–1222; doi: 10.2967/jnumed.115.157032). The purpose of the study was to estimate the […]
Read More >
Jul 31 2015

Recent Advances in Radioembolism Therapy for the Treatment of Liver Cancer
Welcome to the first in our new monthly “Recent Advances” blog series, where we bring you the latest developments in the use of NM-related techniques for the diagnosis and/or treatment of common disease. In this inaugural issue we discuss the use of radioembolism therapy for the treatment of liver cancer. Radioembolism involves the injection of […]
Read More >
Jul 21 2015

The Characterization of Multinuclei PET Scanners
  The first article in our new Recent Highlights Series discusses the recent article “Beyond 18F-FDG: characterization of PET/CT and PET/MR scanners for a comprehensive set of positron emitters of growing application – 18F, 11C, 89Zr, 124I, 68Ga, and 90Y” by Soderlund et al. published in the Journal of Nuclear Medicine (doi:10.2967/jnumed.115.156711). The purpose of […]
Read More >
May 26 2015

FDA INSPECTION RESULTS – PET DRUG FACILITIES 2013-2014
When keeping your facility compliant and ready for an FDA audit, its important to have as much information as possible. Below is a list of 2013-2014’s FDA PET Facility audit results. TOP 6 Major Issues Lack of adequate out of specification (OOS) investigations Inadequate media fill validations, aseptic techniques and environmental monitoring Analytical assay methods […]
Read More >